Document:

Exhibit
10.55

 

STOCK
PURCHASE AGREEMENT

 

This
Stock Purchase Agreement (this “Agreement”) is made as of this ___ day of June, 2021, among Deep Green Waste
& Recycling, Inc., a Wyoming corporation (“Buyer”), Jeremy Lyell (the “Shareholder”),
and Lyell Environmental Services, Inc., a Tennessee corporation (the “Company”).

 

RECITALS

 

The
Shareholder owns all of the presently outstanding shares of capital stock of the Company (the “Shares”) and
desires and intends to sell the Shares to Buyer at the price and on the terms and subject to the conditions set forth below.

 

The
Buyer desires and intends to acquire the Shares from the Shareholder at the price and on the terms and subject to the conditions set
forth below.

 

AGREEMENT

 

NOW
THEREFORE, in consideration of the covenants and conditions set forth herein, the parties agree as follows:

 

SECTION
1. DEFINITIONS.

 

The
following terms as used in this Agreement, shall have the meanings set forth in this Section:

 

“Accounts
Receivable” means all rights of the Company to payment from the customers of the Company arising from Seller’s operation
of the Company prior to the Closing Date.

 

“Assets”
means all the tangible and intangible assets, real, personal, or mixed, owned or held by the Company and used or useful in the business,
including the Personal Property, Real Property, the Assumed Contracts and Grants of Authority, the Accounts Receivable, the Intangibles,
and all customer lists and relationships, and other information relating to the Company, but not including the Excluded Assets.

 

“Assumed
Contracts and Grants of Authority” means (a) those Contracts and Grants of Authority hereto designated by Buyer to indicate
that they will be assumed by Buyer at Closing, and (b) and Contracts and Grants of Authority entered into by Seller in the ordinary course
of business between the date hereof and the Closing Date that Buyer expressly agrees to assume at Closing.

 

    	 

    	 

    

 

“Audit”
means the SEC qualified audit of the Company’s 2019, 2020, and YTD 2021 Financial reports, to be purchased by Buyer and undertaken
immediately upon execution of the Agreement, with the final Auditor’s letter acceptable to Buyer as a condition to Closing.

 

“Company”
means Lyell Environmental Services, Inc., the environmental remediation services company owned by Shareholder, inclusive of the Assets,
customer and vendor relationships, operating methods, brand, and any and all other elements of the enterprise used or useful in its operation.

 

“Closing”
means the consummation of the transaction contemplated by this Agreement in accordance with the provisions of Section 14.

 

“Closing
Date” means the date on which the Closing occurs, as determined pursuant to Section 14.

 

“Common
Stock” means the shares of Common Stock of Buyer to be issued to Shareholder as a component of the consideration for the
purchase of the Shares.

 

“Consents”
means the consents, permits, or approvals of third parties, including governmental authorities, necessary to transfer any of the
Assets to Buyer or otherwise to consummate the transaction contemplated hereby.

 

“Contracts”
means all contracts, leases, non-governmental licenses, and other agreements (including leases for personal or real property and
employment agreements), written or oral, including any amendments or other modifications thereto, that relate to the Company or the operation
of any aspect of the Company together with any additions thereto between the date hereof and the Closing Date.

 

“Effective
Time” means 12:01 a.m. local Nashville, Tennessee time, on the Closing Date.

 

“Excluded
Assets” has the meaning set forth in Section 2.2 below.

 

“Grants
of Authority” means any and all municipal, state, and federal grants of authority and applications therefore, which are
used or useful in connection with the operation of the Company, together with any additions thereto between the date hereof and the Closing
Date.

 

“Intangibles”
means all copyrights, trademarks, service marks, trade names, licenses, patents, permits, privileges, proprietary information, technical
information and data, trade secrets, machinery and equipment warranties, and all other intangible property rights and interests, whether
or not applied for by, or issued to, the Company or under which the Company is licensed or franchised and used or which are, or may be,
useful in, or in any way related to, the business and operations of the Company, together with any additions thereto between the date
hereof and the Closing Date, and all goodwill relating to all of the foregoing.

 

    	2

    	 

    

 

“Personal
Property” means all machinery, equipment, tools, vehicles, furniture, leasehold improvements, office equipment, inventory,
and other tangible personal property used or useful in the operation of the Company, and all data files, plans, diagrams, blueprints,
schematics, and books and records relating to the operation of the Company, filings with governmental agencies, and executed copies of
the Contracts and Grants of Authority, together with any additions thereto between the date hereof and the Closing Date.

 

“Purchase
Price” has the meaning set forth in Section 2.1 below.

 

“Real
Property” means all real estate and all interest in real property, including all leaseholds, easements, licenses used or
useful in the operation of the Business, together with any additions thereto between the date hereof and the Closing Date.

 

“Shares”
means all of the issued and outstanding shares of Lyell Environmental Services, Inc.

 

“Shareholder”
means Jeremy Lyell, who is the sole shareholder of Lyell Environmental Services, Inc.

 

 

SECTION
2. SALE AND PURCHASE OF SHARES.

 

Agreement
to Sell and Buy. Subject to the terms and conditions of this Agreement, at the Closing, the Shareholder shall sell, convey, transfer,
and assign, upon the terms and conditions hereinafter set forth, to Buyer, free and clear of all liens, pledges, claims, and encumbrances
of every kind, nature and description, and Buyer shall purchase and accept from the Shareholder the Shares, which comprise all of the
outstanding capital stock of the Company. Notwithstanding the foregoing or any other provision of this Agreement, the Shareholder shall
retain and shall indemnify the Buyer against any and all losses, claims, settlements, judgments or other liabilities.

 

	2.1.	Purchase
                                            Price. Subject to the terms and conditions set forth in this Agreement, including
                                            adjustments as provided below, Buyer shall purchase the Shares for aggregate consideration
                                            (the “Purchase Price”) as follows:

 

(a)
Upon Buyer’s execution of this Agreement, Buyer shall deliver to ________, Inc. (the “Escrow Agent”)
the sum of fifty thousand dollars ($50,000) (the “Escrow Amount”). The Escrow Amount shall be held by the Escrow
Agent and distributed pursuant to the terms and conditions of the Escrow Agreement attached hereto as Exhibit A, to be entered
into by the Buyer, the Shareholder and the Escrow Agent at or prior to the Closing, and shall be subject to set off, in accordance with
Section 13.5 hereof, in the event that the Company or the Shareholder breach the representations and warranties contained in Section
6 of this Agreement.

 

    	3

    	 

    

 

(b)
At the Closing, the Buyer shall pay to the Shareholder the sum of One Million Three Hundred Thousand Dollars ($1,300,000) by wire transfer
of immediately available funds to such bank account of the Shareholder as the Shareholders shall designate in writing prior to the Closing.

 

(c)
At the Closing, the Buyer shall issue to the Shareholder One Million (1,000,000) shares of Buyer’s common stock (the “Common
Stock”) by Buyer’s Letter of Authorization to its transfer agent.

 

(d)
The Purchase Price shall be adjusted as provided in this Section to give effect to the proration between Buyer and Shareholder of all
revenues and expenses arising from the operation of the Company. The expenses to be prorated shall include business, franchise, and license
fees (including any retroactive adjustments thereof), utility charges, real and personal property taxes and assessments levied against
the Company, property and equipment rentals, amounts due under any of the Assumed Contracts and Grants of Authority and shall receive
all revenues and be responsible for all expenses, costs, and liabilities allocable to the period prior to the effective time of Closing,
and Buyer shall receive all revenues and be responsible for all expenses, costs, and obligations allocable to the period after the effective
time of Closing, except that there shall be no adjustment and Shareholder shall remain solely liable with respect to any obligation or
liability not being assumed by Buyer in accordance with this Section 2.

 

(e)
The Purchase Price, taking into account all adjustments and prorations, will be determined finally, and additional payment to Buyer to
Shareholder or refund by Shareholder to Buyer, as appropriate, will be made, in accordance with the following procedures:

 

		(1)	Within
                                            60 days after the Closing Date, Buyer will deliver to Shareholder a statement setting forth
                                            Buyer’s determination of the amount of the Purchase Price and the calculation thereof,
                                            taking into account all prorations. If Shareholder disputes the amount of the Purchase Price
                                            determined by Buyer, Shareholder shall deliver to Buyer within 30 days after his receipt
                                            of Buyer’s statement a statement setting forth his determination of the amount thereof.
                                            If Shareholder notifies Buyer of his acceptance of Buyer’s statement, or if Shareholder
                                            otherwise fails to deliver his own statement with the 30-day period specified in the preceding
                                            sentence, then Buyer’s determination shall be final, and payment shall be made thereon.

 

		(2)	Buyer
                                            and Shareholder shall use their good faith efforts to resolve any dispute involving the determination
                                            of the Purchase Price. If the parties are unable to resolve the dispute within 15 days following
                                            the delivery of Shareholder’s statement, each of Buyer and Shareholder shall select
                                            an independent arbitrator who shall be knowledgeable and experienced in the operation of
                                            such businesses, and the two arbitrators so chosen shall attempt to resolve the dispute.
                                            If they are not able to do so within 45 days following the delivery of Shareholder’s
                                            statement, the two arbitrators shall agree upon a third arbitrator and the dispute shall
                                            be resolved by the decision of the majority of the arbitrators, which shall be conclusive
                                            and binding on the parties. Any fees of the arbitrators shall be split equally between the
                                            parties.

 

    	4

    	 

    

 

	2.2	Excluded
                                            Assets

 

The
Shareholder shall retain all right title and interest in the following assets (the “Excluded Assets”):

 

		(a)	Shareholder’s
                                            cash on hand or in any of Company’s bank accounts as of the effective time of Closing
                                            except for an amount equal to one twelfth (1/12) of the Company’s reported 2020 revenue,
                                            which shall remain with the Company.

 

		(b)	All
                                            books and records that Shareholder is required by law to retain or that relate solely to
                                            Shareholder’s personal matters.

 

All
of Shareholder’s claims, rights, and interest in and to any refund for federal, state, or local franchise, income, or other taxes
or fees of any nature whatsoever for periods prior to the effective time of the Closing.

 

	2.3	Assumption
                                            of Liabilities and Obligations. 

 

		(a)	Assumption.
                                            Except as provided in paragraph (b) of this Section 2.3, as of the Effective Time, Buyer
                                            shall assume and undertake to pay, discharge, and perform all obligations and liabilities
                                            arising out of events occurring after the Effective Time related to Buyer’s ownership
                                            of the Shares or its operation of the Company after the Effective Time, including, insofar
                                            as they relate to the period after the Effective Time and arise out of events occurring after
                                            the Effective Time, all the obligations and liabilities of the Company under the Assumed
                                            Contracts and Grants of Authority. Buyer shall also assume the Company’s obligations
                                            and liabilities as of the Effective Time with respect to customer deposits and prepayments
                                            from customers. Other than as specified herein, Buyer shall assume no obligations or liabilities
                                            of the Company or the Shareholder.

 

		(b)	Limitation.
                                            Notwithstanding any provision of this Agreement to the contrary, Buyer shall not assume:
                                            (1) any obligations or liabilities under any Contract or Grant of Authority not included
                                            in the Assumed Contracts and Grants of Authority; (2) any obligations or liabilities under
                                            the Assumed Contracts and Grants of Authority relating to the time period prior to the Effective
                                            Time; (3) any claims or pending litigation or proceedings relating to any action with respect
                                            to the operation of the Company prior to the Effective Time; (4) any obligation or liabilities
                                            arising under capitalized leases or other financing agreements; (5) any obligations or liabilities
                                            of the Company or Shareholder under collective bargaining agreements, multi-employer plans
                                            or any other employee benefit plan of the Company; and (6) any obligations or liabilities
                                            caused by, arising out of, or resulting from any action or omission of the Company or Shareholder
                                            prior to the Effective Time, and all such obligations and liabilities shall remain and be
                                            the obligations and liabilities solely of Shareholder.

 

    	5

    	 

    

 

SECTION
3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY AND SHAREHOLDER

 

The
Company and the Shareholder, jointly and severally, represent and warrant to the Buyer as of the date hereof (which representations and
warranties shall survive the Closing as provided in Section 16 of this Agreement) as follows:

 

	 	3.1.1	Good
    Title

 

The
Shareholder owns _______ (_____) shares of the Company’s common stock, no par value, (the “Common Stock”),
which represents all of the issued and outstanding capital stock of the Company, certification of which is attached hereto as Schedule
3.1.1. Such Shares are owned free and clear of any lien, encumbrance, adverse claim, restriction on sale, transfer or voting (other than
restrictions imposed by applicable securities laws), preemptive right, option or other right to purchase, and upon the consummation of
the sale of such Shares as contemplated hereby, the Buyer will have good title to such Shares, free and clear of any lien, encumbrance,
adverse claim, restriction on sale, transfer or voting (other than restrictions imposed by applicable securities laws), preemptive right,
option or other right to purchase.

 

	 	3.1.2	Authority

 

The
Shareholder has all requisite power, right and authority to enter into this Agreement and the documents contemplated hereby (the “Transaction
Documents”) to which he is a party, to consummate the transactions contemplated hereby and thereby, and to sell and transfer
the Shares without the consent or approval of any other person, corporation, partnership, joint venture, organization, other entity or
governmental or regulatory authority (“Person”). The Shareholder has taken, or will take prior to the Closing,
all actions necessary for the authorization, execution, delivery and performance of this Agreement and the other Transaction Documents.

 

	 	3.1.3	Enforceability

 

This
Agreement has been, and the other Transaction Documents to which the Shareholder is a party on the Closing Date will be, duly executed
and delivered by the Shareholder, and this Agreement is, and each of the other Transaction Documents to which he is a party on the Closing
will be, the legal, valid and binding obligation of the Shareholder, enforceable against the Shareholder in accordance with their terms.

 

    	6

    	 

    

 

	 	3.1.4	No
    Approvals or Notices Required; No Conflicts

 

Except
as provided on Schedule 3.1.4, the execution, delivery and performance of this Agreement and the other Transaction Documents by the Shareholder,
and the consummation of the transactions contemplated hereby and thereby, will not (a) constitute a violation (with or without the giving
of notice or lapse of time, or both) of any provision of any law, judgment, decree, order, regulation or rule of any court, agency or
other governmental authority applicable to the Shareholder, (b) require any consent, approval or authorization of, or declaration, filing
or registration with, any Person, (c) result in a default (with or without the giving of notice or lapse of time, or both) under, acceleration
or termination of, or the creation in any party of the right to accelerate, terminate, modify or cancel, any agreement, lease, note or
other restriction, encumbrance, obligation or liability to which the Company is a party or by which it is bound or to which any assets
of the Company are subject, or (d) result in the creation of any lien or encumbrance upon the assets of the Shareholder, or upon the
Shares or other securities of the Company.

 

	 	3.1.5	Securities
    Law Representations and Warranties

 

The
Shareholder has been advised that the Common Stock is not registered under the Securities Act of 1933 (the “Act”),
or applicable state securities laws, but is being issued pursuant to exemptions from such laws, and that the Buyer’s reliance upon
such exemptions is predicated in part on the Shareholder’s representations contained herein. The Shareholder acknowledges that
the Buyer is relying in part upon the Shareholder’s representations and warranties contained herein for the purpose of qualifying
the issuance of the Securities for applicable exemptions from registration or qualification pursuant to federal or state securities laws,
rules and regulations.

 

	 	(a)	Acquired
    Entirely for Own Account

 

The
Common Stock will be issued for the Shareholder’s own account, not as a nominee or agent, and not with a view to distributing all
or any part thereof. The Shareholder has no present intention of selling, granting any participation in or otherwise distributing any
of the Common Stock in a manner contrary to the Act or any applicable state securities law. The Shareholder does not have any contract,
undertaking, agreement or arrangement with any person to sell, transfer or grant participation to such person or to any third person
with respect to any of the Common Stock.

 

	 	(b)	Due
    Diligence

 

The
Shareholder has been solely responsible for his own due diligence investigation of the Buyer and its business, and their analysis of
the merits and risks of the investment made pursuant to this Agreement and are not relying on anyone else’s analysis or investigation
of the Buyer, its business or the merits and risks of the Common Stock other than professional advisors employed specifically by the
Shareholder to assist the Shareholder.

 

    	7

    	 

    

 

	 	(c)	Access
    to Information

 

The
Shareholder believes he has been given access to full and complete information regarding the Buyer, including, in particular, the current
financial condition of the Buyer and the risks associated therewith, and has utilized such access to their satisfaction for the purpose
of obtaining information about the Buyer; particularly, the Shareholder has either attended or been given reasonable opportunity to meet
with the senior executives of the Buyer, for the purpose of asking questions of, and receiving answers from, such persons concerning
the terms and conditions of the issuance of the Common Stock and to obtain any additional information, to the extent reasonably available,
necessary to verify the accuracy of information provided to the Shareholder about the Buyer. No such investigation, however, shall qualify
in any respect the representations and warranties of the Buyer in this Agreement.

 

	 	(d)	Sophistication

 

The
Shareholder, either alone or with the assistance of his professional advisor, is a sophisticated investor, is able to fend for himself
in the transactions contemplated by this Agreement and has such knowledge and experience in financial and business matters that he is
capable of evaluating the merits and risks of the prospective investment in the Common Stock.

 

	 	(e)	Suitability

 

The
investment in the Common Stock is suitable for the Shareholder based upon his investment objectives and financial needs, and the Shareholder
has adequate net worth and means for providing for his current financial needs and contingencies and has no need for liquidity of investment
with respect to the Common Stock. The Shareholder’s overall commitment to investments that are illiquid or not readily marketable
is not disproportionate to his net worth, and investment in the Common Stock will not cause such overall commitment to become excessive.

 

	 	(f)	Professional
    Advice

 

The
Shareholder has obtained, to the extent he deems necessary, his own professional advice with respect to the risks inherent in the investment
in the Common Stock, the condition of the Buyer and the suitability of the investment in the Common Stock in light of the Shareholder’s
financial condition and investment needs.

 

    	8

    	 

    

 

	 	(g)	Ability
    to Bear Risk

 

The
Shareholder is in a financial position to purchase and hold the Common Stock and is able to bear the economic risk and withstand a complete
loss of his investment in the Common Stock.

 

	 	(h)	Restricted
    Securities

 

The
Shareholder realizes that (a) the Common Stock has not been registered under the Act, is characterized under the Act as “restricted
securities” and, therefore, cannot be sold or transferred unless subsequently registered under the Act or an exemption
from such registration is available. The Shareholder’s financial condition is such that it is unlikely that the Shareholder would
need to dispose of any of the Common Stock in the foreseeable future. In this connection, the Shareholder represents that he is familiar
with Rule 144 of the Securities and Exchange Commission (the “SEC”), as presently in effect, and understands
the resale limitations imposed thereby and by the Act.

 

	 	3.2	Company
    Organization, Good Standing; Corporate Authority; Enforceability

 

	 	3.2.1	Organization,
    Good Standing, etc.

 

The
Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Tennessee. The Articles
of Incorporation, Bylaws, and Minutes of the Company, and Certificate of Good Standing dated no more than 10 days prior to execution
of this Agreement from the State of Tennessee are attached hereto as Exhibit B. The Company is duly qualified to do business and is in
good standing in the states where qualification is required due to (a) the Company’s ownership or lease of real or personal property
for use in the operation of the Company’s business or (b) the nature of the business conducted by the Company. The Company has
not at any time owned nor leased any real or personal property, or had any business, operations, obligations, or liabilities under any
assumed or fictitious names. The Company has all requisite power, right and authority to own, operate and lease its properties and assets,
and to carry on its business as now conducted.

 

	 	3.2.2	Corporate
    Authority

 

The
Company has full corporate power and authority to execute and deliver this Agreement and the documents contemplated hereby to which it
is a party and to perform its obligations hereunder and thereunder. The execution and delivery by the Company of this Agreement and the
Transaction Documents to which it is a party, the performance by the Company of its obligations hereunder and thereunder and the consummation
by the Company of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action. This
Agreement constitutes a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, and
the Transaction Documents to which the Company is a party, when executed and delivered by the Company, will constitute valid and binding
obligations of the Company, enforceable against the Company in accordance with their respective terms.

 

    	9

    	 

    

 

	 	3.3	Capitalization

 

(a)
The authorized capital stock of the Company consists of _________ (_______) shares of common stock, without par value (the “Common
Stock”).

 

(b)
The issued and outstanding capital stock of the Company consists and as of the Closing will consist solely of _________ (_____) shares
of Common Stock, all of which are, and as of the Closing Date will be, held of record by the Shareholder. All shares of Common Stock,
that are issued and outstanding are, and as of the Closing Date will be, duly authorized, validly issued, fully paid and nonassessable,
and issued in compliance with all applicable federal, state and foreign securities laws. Except for the Shareholder, no Person holds
any interest in any Shares.

 

(c)
The Company is not a party or subject to any agreement or understanding, and there is no agreement or understanding between any Persons,
that affects or relates to the voting or giving of written consents with respect to any securities of the Company or the voting by any
director of the Company.

 

	 	3.4	Subsidiaries
    and Affiliates

 

The
Company does not have, and has never had, any Subsidiaries. The Company does not own, directly or indirectly, any ownership, equity,
profits or voting interest in, or otherwise control, any corporation, partnership, joint venture or other entity, and has no agreement
or commitment to purchase any such interest.

 

	 	3.5	No
    Conflict

 

Except
as provided on Schedule 3.5, the execution, delivery and performance of this Agreement and/or the Transaction Documents by the Company
and the consummation of the transactions contemplated hereby and thereby will not: (a) violate, conflict with, or result in any breach
of, or constitute a default under, any provision of the Company’s articles of incorporation or by-laws; (b) violate, conflict with,
result in any breach of, or constitute a default (or an event that, with notice or lapse of time or both, would constitute a default)
under, any contract or judgment to which the Company is a party or by which it is bound or which relates to the Company’s business
or assets; (c) result in the creation of any encumbrance, security interest, mortgage, lien, charge, option, license, adverse claim or
restriction of any kind on any of the assets of the Company or upon any Shares or other securities of the Company; (d) violate any applicable
law, statute, rule, ordinance or regulation of any governmental body; (e) give any party with rights under any contract, judgment or
other restriction to which the Company is a party or by which it is bound, the right to terminate, modify or accelerate any rights, obligations
or performance under such contract, judgment or restriction; (f) result in the creation of any lien or encumbrance upon the assets of
the Company, or upon any Shares or other securities of the Company; or (g) invalidate or adversely affect any permit, license, authorization
or status used in the conduct of the business of the Company.

 

    	10

    	 

    

 

	 	3.6	Consents
    and Approvals

 

Except
as set forth in Schedule 3.6, (a) no consent, approval or authorization of, or declaration, filing or registration with, any governmental
body is required for the execution, delivery and performance by the Company of this Agreement and the Transaction Documents to which
it is a party or for the consummation by the Company of the transactions contemplated hereby and thereby and (b) no consent, approval
or authorization of any third party is required for the execution, delivery and performance by the Company of this Agreement and the
Transaction Documents to which it is a party and the consummation by the Company of the transactions contemplated hereby and thereby.

 

	 	3.7	Financial
    Statements

 

The
Company has provided to the Buyer an unaudited balance sheet, dated May 31, 2021 an unuadited operating statement for the one (1) and
five (5)-month periods ended May 31, 2021 and an unaudited statement of cash flows for the five (5)-month period ended May 31, 2021 (collectively,
the “Financial Statements”), attached hereto as Schedule 3.7. The Financial Statements were prepared from the
books and records kept by the Company and fairly present the financial position, results of operations and changes in financial position
of the Company, as of their respective dates and for the periods indicated, in accordance with generally accepted accounting principles
consistently applied. The Company has no liabilities or obligations of any nature (absolute, accrued, or contingent) that are not fully
reflected or reserved against in the balance sheet dated May 31, 2021 (the “Most Recent Balance Sheet”), as
prescribed by generally accepted accounting principles, except liabilities or obligations incurred since the date of the May 31, 2021
Balance Sheet in the ordinary course of business and consistent with past practice. The Company is not a guarantor, indemnitor, surety,
or other obligor of any indebtedness of any other Person.

 

	 	3.8	Absence
    of Undisclosed Liabilities

 

The
Company has no liabilities or obligations, secured or unsecured, whether accrued, absolute, contingent, unasserted or otherwise, except
for liabilities (a) reflected or reserved against in the Most Recent Balance Sheet or (b) incurred in the ordinary course of business
after the date of the Most Recent Balance Sheet and not material in amount, either individually or in the aggregate. The Company has
not entered into or agreed to enter into any transaction, agreement or commitment, suffered the occurrence of any event or events or
experienced any change in financial condition, business, results of operations or otherwise that, in the aggregate, has (i) interfered
with the normal and usual operations of the business or business prospects of the Company or (ii) resulted, or could reasonably be expected
to result, in a material adverse change in the business, assets, operations, prospects or condition (financial or otherwise) of the Company.

 

    	11

    	 

    

 

	 	3.9	Taxes

 

(a)
The Company has timely filed all tax returns and reports (including information returns and reports) as required by law. These returns
and reports are correct and complete in all respects. The Company has paid all taxes and other assessments due. The Company has never
had any tax deficiency proposed or assessed against it and has not executed any waiver of any statute of limitations on the assessment
or collection of any tax or governmental charge. None of the Company’s federal income tax returns and none of its state income
or franchise tax or sales or use tax returns has ever been audited by governmental authorities. Since the date of the Most Recent Balance
Sheet, the Company has not incurred any taxes, assessments, or governmental charges other than in the ordinary course of business. The
Company has established, in accordance with generally accepted accounting principles applied on a basis consistent with that of preceding
periods, and the Most Recent Balance Sheet reflects, adequate reserves for payment of all taxes, assessments and government changes that
have accrued and have not been paid and are incurred in or attributable to taxable periods (or portions thereof) ending on or prior to
the Closing Date. The Company has timely made all deposits required by law to be made with respect to employees’ withholding and
other employment taxes. For purposes of this Agreement, the term “taxes” means all taxes, duties, charges, fees, levies,
or other assessments imposed by any governmental body including income, gross receipts, value-added, excise, unemployment compensation,
withholding, social security, personal property, privilege, real estate, sale, use, ad valorem, license, lease, service, severance,
stamp, intangibles, transfer, payroll, employment, customs, duties, alternative, add-on minimum, estimated, and franchise taxes (including
any interest, penalties, or additions attributable to or imposed on or with respect to any such taxes, duties, charges, fees, levies
or other assessments). For purposes of this Agreement, the term “tax return” means any return, declaration, report, claim
for refund, or information return or statement relating to taxes, including any schedule or attachment thereto, and including any amendment
thereof.

  

	 	3.10	Title
    to Property; Encumbrances

 

(a)
The Company has good and marketable title to all of its properties and assets free and clear of any payment obligation to any third party
or any other lien or encumbrance.

 

(b)
The Company does not own any real property.

 

(c)
With respect to properties and assets it leases, the Company is in compliance with such leases and holds a valid leasehold interest free
of all liens, claims or encumbrances. The Company is not in default under any lease nor does the Company have knowledge of any event
which, after notice or the passage of time or both will constitute a default under any lease.

 

    	12

    	 

    

 

	 	3.11	Environmental
    and Safety Matters

 

The
Company is not in violation of any applicable statute, law or regulation relating to the environment or occupational health and safety.

 

	 	3.12	Contracts

 

Schedule
3.12 contains a complete and accurate list of all contracts, agreements, arrangements, and understandings oral or written, to which the
Company is a party or by which the Company is bound, including, without limitation, all security agreements, intellectual property licenses
and other license agreements, credit agreements, instruments relating to the borrowing of money, leases, rental agreements, purchase
orders, sales orders and sale and distribution agreements (“Contracts”). The Contracts are valid, binding,
and enforceable in accordance with their terms against each party thereto and are in full force and effect; the Company has performed
all obligations imposed on it thereunder. There are not, under any of the Contracts, any defaults, or events of default on the part of
the Company or, to the Company’s knowledge, any other party thereto. True and complete copies of each Contract have been delivered
to Buyer. Except for the Consents described in Section 13.1(c) hereof, no consent is required from any Person under any of the Contracts
in connection with the consummation of the transactions contemplated by this Agreement, and the Company has not received notice, nor
is the Company otherwise aware, that any party to any such contract intends to cancel, terminate, or refuse to renew such contract or
to exercise or decline to exercise any option or right thereunder.

 

	 	3.13	Claims
    and Legal Proceedings

 

Except
as listed in Schedule 3.13, there are no claims pending or, to the Company’s knowledge, threatened against the Company, before
or by any governmental body or nongovernmental department, commission, board, bureau, agency or instrumentality or any other person.
There are no outstanding or unsatisfied judgments, orders, decrees, or stipulations to which the Company is a party.

 

	 	3.14	Labor
    Matters

 

There
are no disputes, material employee grievances or material disciplinary actions pending or, to the Company’s knowledge, threatened
between the Company and any employees of the Company (collectively, the “Employees”). The Company has complied
in all respects with all provisions of all laws relating to the employment of labor and has no liability for any arrears of wages or
taxes or penalties for failure to comply with any such laws. The Company has no knowledge of any organizational efforts presently being
made or threatened by or on behalf of any labor union with respect to any Employees.

 

	 	3.15	Patents,
    Trademarks, and Intellectual Property

 

(a)
The Company has sufficient title and ownership of all patents, trade names, trademarks, service marks, copyrights, net names, trade secrets,
information, proprietary rights, and processes necessary for its business as now conducted and as presently proposed to be conducted
without any conflict with or infringement of the rights of others (the “Intellectual Property”). Schedule 3.15
is an accurate and complete list of all such registered Intellectual Property and applications for any of the foregoing, reflecting dates
of filing or dates of issuance, if applicable.

 

(b)
None of the Intellectual Property or the Company’s rights thereto are being infringed or otherwise violated by any person or entity.

 

(c)
The use of the Intellectual Property by the Company in the operation of its business as now conducted or as proposed to be conducted
does not infringe or otherwise violate any rights of any person or entity, and there is no pending or threatened claim, demand, cause
of action, suit or proceeding, hearing or investigation (each a “Claim”) alleging any such infringement or
violation. In addition, there is no pending or threatened claim alleging any defect in or invalidity, misuse, or unenforceability of,
or challenging the ownership or use of or the Company’s rights, with respect to any of the Intellectual Property and there is no
basis for any such Claim. Furthermore, there is no other Claim made by any person or entity pertaining to the Intellectual Property.
None of the Intellectual Property is subject to any judgement, order, award, writ, injunction or decree of any governmental body or arbitrator.

 

    	13

    	 

    

 

	 	3.16	Licenses,
    Permits, Authorizations, etc.

 

The
Company and the Company’s employees, agents, and representatives have received all governmental approvals, authorizations, consents,
accreditations, certifications, licenses, orders, registrations and permits of all agencies, whether federal, state, local or foreign
(“Permits”) related to the operation of the Company’s business. Schedule 3.16 contains a list of all
Permits with expiration dates, if any. The Company is in compliance with the terms of all Permits, and all Permits are valid and in full
force and effect, and no proceeding is pending or threatened, the object of which is to revoke, limit or otherwise affect any Permit.
The Company has not received any notifications of any asserted failure to obtain any Permit.

 

	 	3.17	Related
    Party Transactions

 

Schedule
3.17 is a complete and accurate list of all contracts or agreements, oral or written, between the Company and the Company’s directors,
officers, shareholders, employees, agents, consultants, advisors, salespeople, sales representatives and distributors or dealers. No
employee, officer, director or shareholder of the Company or member of his or her immediate family (together, “Related Parties”)
is indebted to the Company, nor is the Company indebted (or committed to make loans or extend or guarantee credit) to the Related Parties
in the aggregate in excess of $1,000. No employee, officer or director of the Company has any direct or indirect ownership interest in
any firm or corporation with which the Company is affiliated or with which the Company has a business relationship, or any firm or corporation
that competes with the Company.

 

    	14

    	 

    

 

	 	3.18	Corporate
    Books and Records

 

The
Company has furnished to Buyer true and complete copies of (a) the articles of incorporation and bylaws of the Company as currently in
effect, including all amendments thereto, (b) the minute books of the Company and (c) the stock transfer books of the Company, attached
hereto as Schedule 3.18. Such minutes reflect all meetings of the Company’s shareholders, Board of Directors, and any committees
thereof since the Company’s inception, and such minutes accurately reflect the events of, and actions taken at such meetings. Such
stock transfer books accurately reflect all issuances and transfers of shares of capital stock of the Company since its inception.

  

	 	3.19	Compliance
    With Laws

 

The
Company is and has been in compliance with all laws, statutes, rules, ordinances and regulations promulgated by any governmental body
and all judgments applicable to the operation of its business, to its employees or to its property. The Company has not received notice
of any alleged violation (whether past or present and whether remedied or not), nor is the Company aware of any basis for any claim of
any such violation, of any such law, statute, rule, ordinance, regulation, or judgment.

 

	 	3.20	Insurance

 

Schedule
3.20 is a complete list of all insurance policies maintained by the Company. The Company has maintained insurance protection in such
coverage amounts and deductibles and against all liabilities, claims and risks against which it is customary for corporations engaged
in the Company’s industry or a similar business similarly situated to insure.

 

	 	3.21	Employee
    Plans

 

(a)
Schedule 3.21 contains a complete and accurate list of all employees, their positions, and rates of pay, and a list of all benefit plans,
funds, policies, programs, contracts, arrangements or practices of any kind (including any “employee benefit plan,” as defined
in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”)) and any employment,
consulting or personal services contracts (i) sponsored, maintained or contributed to by the Company or to which the Company is a party,
(ii) covering or benefiting any current or former officer, employee, agent, director or independent contractor of the Company (or any
dependent or beneficiary of any such individual), or (iii) with respect to which the Company has (or could have) any obligation or liability
(each, an “Employee Benefit Plan”). There has been no amendment, interpretation or other announcement (written
or oral) by the Company, any corporation, partnership, limited liability company, sole proprietorship, trade, business or other entity
or organization that, together with the Company, is or was treated as a single employer under Section 414(b), (c), (m) or (o) of the
Code (each, an “ERISA Affiliate”) or any other person relating to, or change in participation or coverage under,
any Employee Benefit Plan that, either alone or together with other such items or events, could materially increase the expense of maintaining
such Employee Benefit Plan (or the Employee Benefit Plans taken as a whole) above the level of expense incurred with respect thereto
for the most recent fiscal year included in the Financial Statements. Neither the Company nor any ERISA Affiliate has any agreement,
arrangement, commitment, or obligation to create, enter into or contribute to any additional Employee Benefit Plan, or to modify or amend
any existing Employee Benefit Plan. The terms of each Employee Benefit Plan permit the Company to amend or terminate such Employee Benefit
Plan at any time and for any reason without penalty and without material liability or expense. None of the rights of the Company under
any Employee Benefit Plan will be impaired in any way by this Agreement or the consummation of the transactions contemplated by this
Agreement.

 

    	15

    	 

    

 

(b)
Each Employee Benefit Plan is, and at all times since inception has been, established, maintained, administered, operated and funded
in all respects in accordance with its terms and in compliance with all applicable laws, statutes, orders, rules and regulations, including,
without limitation, ERISA and the Code. The Company, all ERISA Affiliates, and all other persons (including, without limitation, all
fiduciaries) have, at all times properly performed all of their duties and obligations (whether arising by operation of law or by contract)
under or with respect to such Employee Benefit Plan, including, without limitation, all reporting, disclosure and notification obligations.
Neither the Company nor any ERISA Affiliate has incurred, and there exists no condition or set of circumstances in connection with which
the Company, any ERISA Affiliate or the Buyer could incur, directly or indirectly, any material liability or expense (except for routine
contributions and benefit payments) under ERISA, the Code or any other applicable law, statute, order, rule or regulation, or pursuant
to any indemnification or similar agreement, with respect to any Employee Benefit Plan. Each Employee Benefit Plan that is intended to
be qualified under Section 401(a) of the Code is so qualified and its related trust is exempt from tax under Section 501(a) of the Code.
Nothing has occurred or is reasonably expected by the Company or any ERISA Affiliate to occur that could adversely affect the qualified
status of such Employee Benefit Plan or the tax-exempt status of its related trust. All contributions, premiums and other payments due
or required to be paid to (or with respect to) each Employee Benefit Plan have been timely paid, or, if not yet due, have been accrued
as a liability on the Most Recent Balance Sheet.

 

(c)
Neither the Company nor any ERISA Affiliate sponsors, maintains or contributes to, or has ever sponsored, maintained or contributed to
(or been obligated to sponsor, maintain or contribute to), (i) a multiemployer plan as defined in Section 3(37) or Section 4001(a)(3)
of ERISA, (ii) a multiple employer plan within the meaning of Section 4063 or 4064 of ERISA, or (iii) an “employee benefit plan,”
as defined in Section 3(3) of ERISA, that is subject to Section 412 of the Code, Section 302 of ERISA or Title IV of ERISA.

 

	 	3.22	Full
    Disclosure

 

No
information furnished by or on behalf of the Company to Buyer or its representatives in connection with this Agreement or the transactions
contemplated by this Agreement is false or misleading. In connection with such information and with this Agreement and the transactions
contemplated hereby, the Company has not made any untrue statement of financial or material fact or omitted to state a fact necessary
in order to make the statements made or information delivered, in the light of the circumstances under which they were made or delivered,
not misleading.

 

	 	3.23	Customers
    and Suppliers

 

There
is no indication that any customer or supplier of the Company intends to terminate or modify its relationship with the Company, or that
the consummation of the transactions contemplated by this Agreement and the Transaction Documents will adversely affect the post-Closing
relationship of the Buyer with any of the Company’s customers or suppliers.

 

	 	3.24	Broker

 

No
broker, finder or other financial consultant has acted on behalf of the Company in connection with this Agreement. Shareholder has engaged
Alliant Capital Advisors LLC in connection with this transaction. To the extent that such broker, finder, or other financial consultant
has acted on behalf of the Shareholder, the Shareholder shall indemnify and hold Buyer harmless from any brokers, finders or other consultant
fees or commissions incurred or accrued in connection with this Agreement or the transactions contemplated by this Agreement.

 

	 	3.25	Conduct of Business in Ordinary Course; Adverse Change.

 

Since
December 31, 2020, the Company has conducted its business only in the ordinary course and has not:

 

		(a)	Adverse
                                            Change. Suffered any material adverse change in the business, assets, properties, prospects,
                                            or condition (financial or otherwise) of the Company, or any damage, destruction, or loss
                                            affecting any of the assets used or useful in the conduct of its business,

 

		(b)	Liens.
                                            Created, assumed, or suffered any mortgage, pledge, lien, or encumbrance on any of the assets,

 

		(c)	Employee
                                            Compensation. Suffered any material increase in compensation payable or to become payable
                                            to any of the employees of the Company, or any bonus payment made or promised to any employee
                                            of the Company, or any material change in personnel policies, insurance benefits, or other
                                            compensation arrangements affecting the employees of the Company,

 

    	16

    	 

    

 

		(d)	Dispositions.
                                            Suffered any sale, assignment, lease, material depletion of inventory, or other transfer
                                            of any of the Company’s properties without suitable replacements being obtained therefore,

 

		(e)	Cancellation
                                            of Debts. Cancelled any debts owed to or claims held by the Company,

 

		(f)	Write-Down.
                                            Suffered any significant write-down of the value of any assets or any significant write-off
                                            as uncollectible of any Accounts Receivable; and

 

		(g)	Rights.
                                            Transferred or granted any right under or entered into any settlement regarding the breach
                                            or infringement of, any license, patent, copyright, trademark, trade name, grant of authority,
                                            or other intellectual property or proprietary right, or modified any existing right relating
                                            to the Company.

 

3.26.
Information Regarding the Business 

 

Accounts.
All the account balances of customers to the Company are actual and bona fide receivables representing obligations for the total dollar
amount thereof, as shown on the books of Company, resulted from the regular course of the Company’s business, and are fully collectible
in accordance with their terms, subject to no offset or reduction whatsoever. The Company has no monetary obligations or liabilities
to any of its customers except with respect to any deposits and prepayments disclosed in Schedule 3.26.

 

3.27
Full Disclosure.

 

No
representation or warranty made by Shareholder or the Company in this Agreement or in any certificate, document, or other instrument
furnished or to be furnished by the Company or Shareholder pursuant hereto contains or will contain any untrue statement of a material
fact or omits or will omit to state any material fact required to make any statement contained herein or therein not misleading. Shareholder
or the Company is not aware of any impending or contemplated event or occurrence that would cause any of the foregoing representations
not to be true and complete on the date of such event or occurrence as if made on that date.

 

SECTION
4. REPRESENTATIONS AND WARRANTIES OF BUYER

 

Buyer
represents and warrants to Seller as follows:

 

		4.1	Organization,
                                            Standing, and Authority. Buyer is a corporation duly organized, validly existing,
                                            and in good standing under the laws of the State of Wyoming. On the Closing Date, Buyer will
                                            be duly qualified to conduct its business in the States of Tennessee and Kentucky. Buyer
                                            has the requisite power and authority to execute, deliver, and perform this Agreement and
                                            the documents contemplated hereby according to their respective terms.

 

		4.2	Authorization
                                            and Binding Obligation. The execution, delivery, and performance of this Agreement
                                            by Buyer have been duly authorized by all necessary action on the part of Buyer. This Agreement
                                            has been duly executed and delivered by Buyer and constitutes a legal, valid, and binding
                                            obligation of Buyer, enforceable against Buyer in accordance with its terms except as the
                                            enforceability hereof may be affected by bankruptcy, insolvency, or similar laws affecting
                                            creditors’ rights generally and by judicial discretion in the enforcement of equitable
                                            remedies.

 

		4.3	Absence
                                            of Conflicting Agreements and Required Consents. Subject to obtaining the Consents,
                                            the execution, delivery, and performance of this Agreement and the documents contemplated
                                            hereby (with or without the giving of notice, the lapse of time, or both): (a) do not require
                                            the consent of any third party; (b) will not conflict with the by-laws of the Buyer; (c)
                                            will not conflict with, result in a breach of, or constitute a default under, any applicable
                                            law, judgment, order, ordinance, injunction, decree, rule, regulation, or ruling of any court
                                            or governmental instrumentality; and (d) will not conflict with, constitute grounds for termination
                                            of, result in a breach of, constitute a default under, or accelerate or permit the acceleration
                                            of any performance required by the terms of any agreement, instrument, license or permit
                                            to which Buyer is a party or by which Buyer may be bound, such that Buyer could not acquire
                                            or operate the Assets.

 

		4.4	Broker.
                                            Neither Buyer nor any person or entity acting on its behalf has agreed to pay a commission,
                                            finder’s fee, or similar payment in connection with this Agreement or any matter related
                                            hereto to any person or entity, nor has it or any person or entity acting on its behalf taken
                                            any action on which a claim for any such payment could be based.

 

		4.5	Full
                                            Disclosure. No representation or warranty made by Buyer in this Agreement or in any
                                            certificate, document, or other instrument furnished or to be furnished by Buyer pursuant
                                            hereto contains or will contain any untrue statement of a material fact or omits or will
                                            omit to state any material fact required to make any statement contained herein or therein
                                            not misleading. Buyer is not aware of any impending or contemplated event or occurrence that
                                            would cause any of the foregoing representations not to be true and complete on the date
                                            of such event or occurrence as if made on that date.

 

    	17

    	 

    

 

SECTION
5. CONDITIONS PRECEDENT TO BUYER’S OBLIGATIONS

 

The
Buyer’s obligations under this Agreement are subject to the satisfaction of each of the following conditions, each of which is
material, for the sole benefit of the Buyer and may be waived only in writing by the Buyer:

 

	 	5.1	Representations
    and Warranties

 

The
representations of the Company and the Shareholder contained in Section 3 of this Agreement shall be true on and as of the Closing Date
with the same effect as though such representations and warranties had been made on and as of the Closing Date.

 

	 	5.2	Performance
    of Agreements

 

The
Company and the Shareholders shall have duly performed and complied with all covenants and obligations contained in this Agreement or
any other Transaction Document that are required to be performed or complied with by them on or before the Closing Date.

 

	 	5.3	Officer’s
    Certificate

 

The
Buyer shall have received a certificate of an officer of the Company, in a form reasonably acceptable to Buyer, dated the Closing Date,
certifying that the conditions set forth in Sections 5.1, 5.2, 5.4, 5.6, 5.7, 5.9, 5.11, 5.12, and 5.13, have been fulfilled.

 

	 	5.4	Shareholder’s
    Certificate

 

The
Buyer shall have received a certificate of the Shareholder, in a form reasonably acceptable to the Buyer, dated the Closing Date, certifying
that the conditions set forth in Sections 5.1, 5.2, 5.5, 5.6, 5.7, 5.8, 5.9, 5.10, 5.11, 5.12, and 5.13 have been fulfilled.

  

	 	5.5	Approvals

 

All
transfers of Permits and all approvals, applications, or notices to public agencies, federal, state, local or foreign, the granting or
delivery of which is necessary for the consummation of the transactions contemplated hereby or for the continued operation of the Company
shall have been obtained, and all waiting periods specified by law with respect thereto shall have passed. All such transfers and approvals
shall be reasonably satisfactory in all respects to the Buyer.

 

	 	5.6	Resignation

 

The
Buyer shall have received the Shareholder’s resignation, as the sole officer and director of the Company, effective as of the Closing.

  

	 	5.7	Delivery
    of Certificates

 

The
Shareholder shall have delivered to the Buyer certificates representing the Shares, duly endorsed for transfer on the Company’s
books.

 

	 	5.8	Escrow
    Agreement

 

The
Escrow Agent and the Shareholders shall have executed and delivered the Escrow Agreement.

  

	 	5.9	Payment
    of Liabilities

 

Prior
to the Closing Date, the Shareholder shall cause all liabilities of the Company to be satisfied, including but not limited to those liabilities
arising under any employment agreements with employees of the Company, which were executed prior to the Closing Date, and shall indemnify,
hold harmless and release the Company from such liabilities, except those liabilities listed on Schedule 5.9 attached hereto (the “Permitted
Liabilities”) and those liabilities which shall be released after the Closing Date pursuant to Section 14.3 hereof.

 

	 	5.10	Bank
    Accounts

 

Authority
to act on behalf of the Company shall be transferred to Lloyd Spencer, Chief Executive Officer; Bill Edmonds, Interim Financial Officer;
and David Bradford, Chief Operating Officer of the Buyer, in connection with all banks, trust companies, savings and loan associations
and other financial institutions at which the Company maintains safe deposit boxes or accounts.

 

	 	5.11	Termination
    of Options and Warrants

 

All
options, warrants and other contractual rights to purchase capital stock of the Company shall have expired or been terminated.

 

	 	5.12	Due
    Diligence

 

The
results of the Buyer’s due diligence investigation of the Company and the Shareholder as it relates to the Shares shall be satisfactory
in all respects to the Buyer.

 

	 	5.13	No
    Adverse Changes

 

From
the date of this Agreement to the Closing Date, there shall not have been any material adverse change in (a) the business, operations,
assets, liabilities, earnings, condition (financial or otherwise) or prospects of the Company or (b) with respect to the Shareholder
and the Shares, and no material adverse change shall have occurred (or be threatened) in any domestic or foreign laws affecting the Company
or in any third party contractual or other business relationships of the Company.

 

    	18

    	 

    

 

SECTION
6. CONDITIONS TO THE COMPANY’S AND SHAREHOLDER’S OBLIGATIONS

 

The
Company’s and Shareholder’s obligations under this Agreement are subject to the satisfaction of the following conditions:

 

	 	6.1	Representations
    and Warranties

 

The
representations of the Buyer contained in Section 6 of this Agreement shall be true on and as of the Closing Date with the same effect
as though such representations and warranties had been made on and as of the Closing Date.

 

	 	6.2	Performance
    of Agreements

 

Buyer
shall have duly performed and complied with all covenants and obligations contained in this Agreement or any other Transaction Document
that are required to be performed or complied with by it on or before the Closing Date.

 

	 	6.3	Escrow
    Agreement

 

The
Escrow Agent and the Buyer shall have executed and delivered the Escrow Agreement.

  

SECTION
7. COVENANTS OF SHAREHOLDER AND THE COMPANY

 

7.1
Pre-Closing Covenants. Shareholder and the Company covenant and agree that from and after the close of the financial period
ending May 31, 2021 as reflected by the financial statements provided pursuant to Section 3.7 above and between the date hereof and the
Closing Date, Shareholder and the Company has conducted, and will have conducted, its business diligently, in the ordinary course, and
in such a manner so that the representations and warranties contained in Section 3 shall continue to be true on and as of the Closing
Date as if made on and as of the Closing Date, and, except with the prior written consent of Buyer, Shareholder and the Company has acted,
and will, from the date of this Agreement, act, in accordance with the following:

 

		(a)	Contracts.
                                            The Company will not enter into any contract or commitment relating to the Company or the
                                            Assets or amend or terminate any Contract of Grant of Authority (or waive any substantial
                                            right thereunder) or incur any obligation (including obligations relating to the borrowing
                                            of money or guarantee of indebtedness).

 

    	19

    	 

    

 

		(b)	Encumbrances.
                                            The Company will not create, assume, or permit to exist any mortgage, pledge, lien, or other
                                            charge or encumbrance of rights affecting any of the Assets, except for those in existence
                                            on the date of this Agreement except for mechanics’ liens and other similar liens which
                                            will be discharged prior to the Closing Date.

 

		(c)	Dispositions.
                                            The Company will not sell, assign, lease, or otherwise transfer or dispose of any of the
                                            Assets except in the ordinary course of business where no longer used or useful or in connection
                                            with the acquisition of replacement property of equivalent kind and value.

 

		(d)	Grants
                                            of Authority. The Company will not cause or permit, by any act or failure to act, any
                                            of the Grants of Authority to expire or to be surrendered or modified, or take any action
                                            that would cause any governmental authority to institute proceedings for the suspension,
                                            revocation, or adverse modification of any of the Grants of Authority, or fail to prosecute
                                            with due diligence any pending applications to any governmental authority in connection with
                                            the operation of the Company, or take any other action within its control that would result
                                            in the Company being in noncompliance with the requirements of any law, the rules and regulations
                                            of any governmental authority, or the terms of any Grant of Authority.

 

		(e)	Consents.
                                            The Company will obtain the Consents, without any change in the terms or conditions of any
                                            Contract that could be less advantageous to the Company than those pertaining under the Contract
                                            as in effect on the date hereof. Shareholder or the Company will promptly advise Buyer of
                                            any difficulties experienced in obtaining any of the Consents and of any conditions proposed,
                                            considered, or requested for any of the Consents.

 

		(f)	Books.
                                            The Company will maintain the books and records of the company in accordance with prior practice.

 

		(g)	Access
                                            to Information. The Company will give to Buyer and its counsel, accountants, engineers,
                                            and other authorized representatives, reasonable access to the Assets, to the officers, employees,
                                            and agents of the Company, and to all books and records relating thereto, and will furnish
                                            or cause to be furnished to Buyer and its authorized representatives all information relating
                                            to the Assets and Seller that they reasonably request (including any financial reports and
                                            operations reports produced with respect to the company).

 

		(h)	Notification.
                                            The Company will give Buyer prompt written notice of any material change in any of the information
                                            contained in its representations and warranties in this Agreement or in the Schedules referred
                                            to herein and of any occurrence involving the Business or any Assets and not arising in the
                                            ordinary course of the company.

 

    	20

    	 

    

 

		(i)	Maintenance
                                            of Assets. The Company will maintain all of the company’s property and Assets or
                                            replacements thereof in their present condition as represented in this Agreement, ordinary
                                            wear and tear excepted. Seller will maintain supplies of inventory and spare parts consistent
                                            with past practice. If any loss, damage, impairment, confiscation, or condemnation to any
                                            of the Assets occurs, The Company shall repair, replace, or restore the Assets to their prior
                                            condition as represented herein as soon thereafter as possible, and the Company will use
                                            the proceeds of any claim under any insurance policy solely to repair, replace, or restore
                                            any of the Assets that are lost, damaged, impaired, or destroyed.

 

		(j)	Compliance
                                            with Laws. The Company will comply with all laws, rules, and regulations. Upon receipt
                                            of notice of violation of any law, rule, or regulation, The Company will contest in good
                                            faith or cure the violation prior to the Closing Date.

 

		(k)	Insurance.
                                            The Company will maintain in force the existing hazard and liability insurance policies,
                                            or comparable coverage, for the company and the Assets, and it will use the proceeds of any
                                            claims for loss payable under those insurance policies to repair, replace, or restore any
                                            of the Assets destroyed by fire or other casualty to their former condition as soon as possible
                                            after the loss.

 

		(l)	Financial
                                            Information. Within fifteen days after the close of each calendar month, the Company
                                            will furnish to Buyer an unaudited statement of income and expense of the Company for the
                                            month and an unaudited balance sheet of the Company as at the close of the month. The financial
                                            statements to be delivered hereunder shall be complete and correct, shall be prepared in
                                            accordance with generally accepted accounting principles applied and maintained on a basis
                                            consistent with prior periods, shall accurately reflect the books, records, and accounts
                                            of the company, and shall present fairly the financial condition, assets, liabilities, and
                                            results of operations of the company as of the dates and for the periods indicated. The Company
                                            shall furnish to Buyer as it becomes available any other information prepared by Seller concerning
                                            the financial condition of the company.

 

		(m)	Preservation
                                            of Business. The Company will preserve the business and organization of the company intact
                                            and use its best efforts to keep available to the Company its present employees and to preserve
                                            for the company its present relationships with suppliers and customers and others having
                                            business relations with them, to the end that the business, operations, and prospects of
                                            the Company shall be unimpaired at the Closing Date. The ordinary and customary operating,
                                            marketing, promotional, sales, and advertising practices of the company shall be maintained.

 

		(n)	Collection
                                            of Accounts Receivable. The Company shall collect its Accounts Receivable only in the
                                            ordinary course consistent with its past practices and without extraordinary efforts of any
                                            kind.

 

    	21

    	 

    

 

		(o)	Rates.
                                            The Company will not directly or indirectly modify or amend any rate, charge, deposit, or
                                            other material condition under which it does business with its customers and potential customers.

 

		(p)	No
                                            Inconsistent Action. The Company will not take any action that is inconsistent with its
                                            obligations under this Agreement or that could hinder or delay the consummation of the transactions
                                            contemplated by this Agreement.

 

		(q)	Financing
                                            Leases. The Company will satisfy prior to Closing all outstanding obligations under capital
                                            and financing leases with respect to any of the Assets and obtain good title to the Assets
                                            leased by Company pursuant to those leases so that those Assets shall be transferred to Buyer
                                            at Closing free of any interest of the lessors.

 

7.2
Closing Covenant. On the Closing Date, if the conditions set forth in Section 8.2 have been satisfied, the Company and Shareholder
shall transfer, convey, assign, and deliver to Buyer the Shares as provided in Section 2 of this Agreement and make the deliveries provided
in Section 14.3 of this Agreement.

 

SECTION
8. CLOSING COVENANT OF BUYER

 

On
the Closing Date, if the conditions set forth in Section 7 have been satisfied, Buyer shall purchase the Shares from Shareholder as provided
in Section 2 of this Agreement and shall make the deliveries provided in Section 14.3 of this Agreement.

 

SECTION
9. SPECIAL COVENANTS AND AGREEMENTS

 

9.1
Further Action Upon the terms and subject to the conditions hereof, each of the parties shall (a) make promptly its respective
filings, and thereafter make any other required submissions, under applicable laws with respect to the transactions contemplated hereby
and shall cooperate with the Buyer with respect to such filings and submissions and (b) use its best efforts to take, or cause to be
taken, all appropriate action, and to do, or cause to be done, all things necessary, proper or advisable under applicable laws and regulations
to consummate and make effective the transactions contemplated hereby, including, without limitation, using its best efforts to obtain
all waivers, licenses, permits, consents, approvals, authorizations, qualifications and orders of governmental authorities and parties
to contracts as are necessary for the consummation of the transactions contemplated hereby and to fulfill the conditions to the closing
of the sale of the Shares to the Buyer. In case at any time after the Closing Date any further action is necessary or desirable to carry
out the purposes of this Agreement, each party to this Agreement shall use its best efforts to take all such action. None of the Buyer,
the Company or the Shareholder will undertake any course of action inconsistent with this Agreement or that would make any representations,
warranties or agreements made by such party in this Agreement untrue or any conditions precedent to this Agreement unable to be satisfied
at or prior to the Closing.

 

    	22

    	 

    

 

9.2
Risk of Loss. The risk of any loss, damage, impairment, confiscation, or condemnation of any of the Assets from any cause whatsoever
shall be borne by Seller at all times prior to the Closing.

 

9.3
Confidentiality. Each party hereto will keep confidential any information obtained from the other party in connection with the
transactions contemplated by this Agreement, except as and to the extent required by applicable law and, in the case of Buyer, as disclosure
may be reasonably required in connection with Buyer’s review and financing of this transaction and with respect to required securities
filings or notices. If this Agreement is terminated, each party will return to the other party all information obtained from the other
party in connection with the transactions contemplated hereby.

 

9.4
Cooperation. Buyer and Shareholder shall cooperate fully with each other and their respective counsel and accountants in connection
with any actions required to be taken as part of their obligations under this Agreement, and Buyer and Shareholder will use their best
efforts to consummate the transactions contemplated hereby and to fulfill their obligations hereunder.

 

9.5
Access. To the extent possible, for a period of five years after the Closing Date, Shareholder shall provide Buyer reasonable
access and the right to copy any books and records relating to the Company that are not included in the Assets, and Buyer will provide
Shareholder access to any books and records relating to the Company that are included in the Assets.

 

9.6
Covenant Not to Compete.

 

		(a)	Shareholder.
                                            In consideration of the sums to be paid pursuant to the terms of this Agreement, and in order
                                            to protect the Company (and the value of the Shares), Shareholder agrees that if the Closing
                                            occurs he shall not, either, directly or indirectly through other persons or their respective
                                            affiliates, engage in, carry on, or be connected to any waste management business; provided,
                                            however, nothing herein shall prohibit Shareholder from being a passive owner of not more
                                            than two percent (2%) of the outstanding stock of any class of any corporation that engages
                                            in such business, so long as (i) such Shareholder have no active participation in the business
                                            of such corporation, and (ii) such stock is traded on a nationally-recognized stock market
                                            or on NASDAQ. The provisions of this Section 9.6 shall be binding upon Shareholders for a
                                            period of three (3) years from the date of the Closing. It is the intent and understanding
                                            of each party hereto that if, in any action before any court or agency legally empowered
                                            to enforce this Section 9.6, any term, restriction, covenant or promise shall be deemed modified
                                            to the extent necessary to make it enforceable to the greatest extent possible by such court
                                            or agency.

 

    	23

    	 

    

 

		(b)	Other
                                            Provisions. For purposes of this Section, an affiliate means (a) any partnership, corporation,
                                            or other entity directly or indirectly controlling, controlled by, or under common control
                                            with Shareholder signing below, or (b) any officer, director, manager, trustee, or principal
                                            of Shareholder or of any partnership, corporation, or other entity that is an affiliate under
                                            this definition. The parties acknowledge and agree that the covenants set forth in this Section
                                            9.6 are ancillary to the sale of the Shares and are reasonable and necessary to protect Buyer’s
                                            purchase of the Shares.

 

SECTION
10. TAXES

 

(a)
The Shareholder shall be responsible for the payment of all transfer, sales and use and documentary taxes, filing and recording fees
and similar charges that may be payable in connection with the transactions contemplated by this Agreement.

 

(b)
Buyer shall prepare, or cause to be prepared, and file, or cause to be filed, all tax returns of the Company for all periods ending on
or prior to the Closing Date (which are filed after the Closing Date) and for all periods that began before the Closing Date and end
after the Closing Date.

 

(c)
The Shareholder agrees that he will join with the Buyer and the Company to timely make the election provided for under Section 338(h)(10)
of the Code in connection with the consummation of the transactions contemplated hereby (the “Section 338(h)(10) Election”).
The Shareholder will include any income, gain, loss, or deduction resulting from the Section 338(h)(10) Election on his tax returns to
the extent required by applicable law. The Purchase Price, liabilities of the Company and other relevant items shall be allocated in
accordance with the allocation set forth on a schedule which shall be prepared by the Buyer and provided to the Shareholder within 90
days following the Closing Date.

 

SECTION
11. TRANSACTION COSTS

 

Each
party shall be responsible for its own costs and expenses incurred in connection with the preparation, negotiation and delivery of this
Agreement and the Transaction Documents, including but not limited to attorneys’ and accountants’ fees and expenses; except
that in no event shall any of such costs or expenses be borne by or charged to the Company.

 

SECTION
12. ATTORNEYS’ FEES AND COSTS

 

In
the event that a party commences a legal proceeding to enforce its rights under this Agreement, the substantially prevailing party shall
be entitled to recover its attorneys’ fees and costs from the non-prevailing party or parties, including those incurred in any
arbitration, bankruptcy or appeal procedure.

 

    	24

    	 

    

 

SECTION
13. CONDITIONS TO OBLIGATIONS OF BUYER AND SELLER

 

13.1
Conditions to Obligations of Buyer. All obligations of Buyer at the Closing hereunder are subject at Buyer’s option
to the fulfillment prior to or at the Closing Date of each of the following conditions:

 

		(a)	Representations
                                            and Warranties. All representations and warranties of the Company and Shareholder contained
                                            in this Agreement shall be true and complete in all material respects at and as of the Closing
                                            Date as though made at and as of that time.

 

		(b)	Covenants
                                            and Conditions. Shareholder and the Company shall have performed and complied in all
                                            material respects with all covenants, agreements, and conditions required by this Agreement
                                            to be performed or complied with by it prior to or at the Closing Date.

 

		(c)	Consents.
                                            All Consents shall have been obtained and delivered to Buyer, without any change in the terms
                                            or conditions of any Contract that could be less advantageous to the Company than those pertaining
                                            under the Contract as in effect on the date hereof.

 

		(d)	Governmental
                                            Authorizations. The Company shall be the holder of all Grants of Authority, and there
                                            shall not have been any modification of any of the Grants of Authority that could have an
                                            adverse effect on the Company or the conduct of its operations. No proceeding shall be pending,
                                            the effect of which would be to revoke, cancel, fail to renew, suspend, or modify adversely
                                            any Grants of Authority.

 

		(e)	Deliveries.
                                            Shareholder and the Company shall have made or stand willing to make all the deliveries to
                                            Buyer set forth in Section 14.2.

 

		(f)	Audit
                                            Complete. Buyer shall have received a final letter from the SEC qualified audit of the
                                            Company’s financial statements.

 

		13.2	Conditions
                                            to Obligations of Shareholder. All obligations of Shareholder and the Company at
                                            the Closing hereunder are subject at Shareholder and the Company’s option to the fulfillment
                                            prior to or at the Closing Date of each of the following conditions:

 

		(a)	Representations
                                            and Warranties. All representations and warranties of Buyer contained in this Agreement
                                            shall be true and complete in all material respects at and as of the Closing Date as though
                                            made at and as of that time.

 

    	25

    	 

    

 

		(b)	Covenants
                                            and Conditions. Buyer shall have performed and complied in all material respects with
                                            all covenants, agreements, and conditions required by this Agreement to be performed or complied
                                            with by it prior to or at the Closing Date.

 

SECTION
14. CLOSING AND CLOSING DELIVERIES

14.1
Closing.

 

		(a)	Closing
                                            Date. The Closing shall take place at 10:00 a.m. on the date which is 15 days after Buyer’s
                                            receipt of the final Audit Letter or an earlier or later date to be set by Buyer which is
                                            within fifteen days following the satisfaction or waiver of all conditions to closing set
                                            forth in this Agreement.

 

		(b)	Closing
                                            Place. The Closing shall be held at the offices of the Company in Nashville, Tennessee,
                                            or any other place that is agreed upon by Buyer and Shareholder.

 

14.2
Deliveries by Shareholder. Prior to or on the Closing Date, Shareholder shall deliver to Buyer the following, in form and
substance reasonably satisfactory to Buyer and its counsel:

 

		(a)	Transfer
                                            Documents. Duly executed warranty deeds, bills of sale, assignments, and other transfer
                                            documents which shall be sufficient to vest good title to the Assets in the name of Buyer,
                                            free and clear of all mortgages, liens, restrictions, encumbrances, claims, and obligations
                                            except as permitted in this Agreement,

 

		(b)	Consents.
                                            A manually executed copy of each Consent,

 

		(c)	Resolutions.
                                            Copies of resolutions adopted by the Board of Directors and, if required, shareholder of
                                            Company, authorizing and approving the execution of this Agreement and the consummation of
                                            the transactions contemplated hereby on the Closing Date,

 

		(d)	Certificate
                                            of Compliance. A certificate, dated as of the Closing Date, executed by the President
                                            of the Company, certifying: (1) that Shareholder and the Company have obtained proper corporate
                                            authorization necessary to the consummation of this Agreement; (2) that the representations
                                            and warranties of Shareholder and the Company contained in this Agreement are true and complete
                                            in all material respects as of the Closing Date as though made on and as of that date; and
                                            (3) that Shareholder and the Company have, in all material respects, performed and complied
                                            with all of its obligations, covenants, and agreements set forth in this Agreement to be
                                            performed and complied with on or prior to the Closing Date;’

 

    	26

    	 

    

 

		(e)	Licenses,
                                            Contracts, Business Records, Etc. Copies of any Grants of Authority, contracts, blueprints,
                                            schematics, working drawings, plans, projections, statistics, and all files and records used
                                            by Seller in the operations of the Company,

 

		(f)	Accounts
                                            Receivable. A complete and accurate list of the Accounts Receivable, including, with
                                            respect to each account Receivable, the account number, date of issuance, name and address
                                            of account debtor, aggregate amount, and balance due, together with any resolution or other
                                            documents that Buyer reasonably requests to permit Buyer to deposit any collections on any
                                            Accounts Receivable into its bank accounts.

 

14.3
Deliveries by Buyer. Prior to or on the Closing Date, Buyer shall deliver to Shareholder the following, in form and substance
reasonably satisfactory to Shareholder and its counsel:

 

		(a)	Consideration.
                                            The consideration for the Shares as provided in Section 2.1, subject to Sections 2.2 and
                                            2.3 above,

 

		(b)	Certificate
                                            of Compliance. A certificate, dated as of the Closing Date, executed on behalf of Buyer
                                            by its President, certifying (1) that the representations and warranties of Buyer contained
                                            in this Agreement are true and complete in all material respects as of the Closing Date as
                                            though made on and as of that date, and (2) that Buyer has, in all material respects, performed
                                            and complied with all of its obligations, covenants, and agreements set forth in this Agreement
                                            to be performed and complied with on or prior to the Closing Date.

 

SECTION
15. TERMINATION

 

This
Agreement may be terminated by either Buyer or Shareholder, if the terminating party is not then in material default, upon written notice
to the other party, upon the occurrence of any of the following:

 

		(a)	Conditions.
                                            If on the Closing Date any of the conditions precedent to the obligations of the terminating
                                            party set forth in this Agreement have not been satisfied or waived in writing by the terminating
                                            party.

 

		(b)	Judgments.
                                            If there shall be in effect on the Closing Date any judgment, decree, or order that would
                                            prevent or make unlawful the Closing of this Agreement.

 

		(c)	Upset
                                            Date. If the Closing shall not have occurred prior to September 15, 2021, provided, however
                                            that Buyer may elect to extend this date by 30 days upon giving written notice to Shareholder
                                            pursuant to section 18.2 herein.

 

    	27

    	 

    

 

SECTION
16. SURVIVAL OF REPRESENTATIONS AND WARRANTIES AND INDEMNIFICATION.

 

16.1
Representation and Warranties. All representations, warranties, and covenants not to compete contained in this Agreement
shall be deemed continuing representations, warranties and covenants and shall survive the Closing. Any investigations by or on behalf
of any party hereto shall not constitute a waiver as to enforcement of any representation, warranty, or covenant contained herein. No
notice or information delivered by Shareholder pursuant to Section 7.1(g) or Section 7.1(h) shall modify or limit any of Shareholder’s
representations and warranties, affect Buyer’s right to rely on any representation or warranty made by Shareholder, or relieve
Shareholder of any obligations hereunder as the result of a breach of any of its representations and warranties.

 

16.2
Indemnification by Shareholder. Notwithstanding the Closing, and regardless of any investigation made at any time by or
on behalf of Buyer or any information Buyer may have, Shareholder agrees to indemnify and hold Buyer harmless against and with respect
to, and shall reimburse Buyer for:

 

		(a)	Breach.
                                            Any and all losses, liabilities, or damages resulting from any untrue representation, breach
                                            of warranty, or nonfulfillment of any covenant by Seller contained herein or in any certificate,
                                            document, or instrument delivered to Buyer hereunder,

 

		(b)	Obligations.
                                            Any and all obligations of Seller not assumed by Buyer pursuant to the terms of this Agreement,
                                            including any and all liabilities arising at any time under any Contract or Grant of Authority
                                            not included in the Assumed Contracts and Grants of Authority,

 

		(c)	Ownership.
                                            Any and all losses, liabilities, or damages resulting from the operation or ownership of
                                            the Business prior to the Effective Time, including any and all liabilities arising under
                                            the Grants of Authority or the Contracts which relate to events occurring prior to the Effective
                                            Time; and

 

		(d)	Legal
                                            Matters. Any and all actions, suits, proceedings, claims, demands, assessments, judgments,
                                            costs, and expenses, including reasonable legal fees and expenses, incident to any of the
                                            foregoing or incurred in investigating or attempting to avoid the same or to oppose the imposition
                                            thereof, or in enforcing this indemnity.

 

    	28

    	 

    

 

16.3
Indemnification by Buyer. Notwithstanding the Closing, and regardless of any investigation made at any time by or on behalf
of Shareholder or the Company or any information Shareholder or the Company may have, Buyer hereby agrees to indemnify and hold Shareholder
and the Company harmless against and with respect to, and shall reimburse Shareholder or the Company for:

 

		(a)	Breach.
                                            Any and all losses, liabilities, or damages resulting from any untrue representation, breach
                                            of warranty, or nonfulfillment of any covenant by Buyer contained herein or in any certificate,
                                            document, or instrument delivered to Shareholder or the Company hereunder,

 

		(b)	Ownership.
                                            Any and all losses, liabilities, or damages resulting from the operation or ownership of
                                            the Company after the Effective Time, including any and all liabilities arising under the
                                            Assumed Contracts and Grants of Authority which relate to events occurring after the Effective
                                            Time, but in all instances excluding any liabilities arising under any Excluded Assets; and

 

		(c)	Legal
                                            Matters. Any and all actions, suits, proceedings, claims, demands, assessments, judgments,
                                            costs and expenses, including reasonable legal fees and expenses, incident to any of the
                                            foregoing or incurred in investigating or attempting to avoid the same or to oppose the imposition
                                            thereof, or in enforcing this indemnity; and

 

		(d)	Obligations.
                                            Any and all obligations of Buyer not assumed by Shareholder pursuant to the terms of this
                                            Agreement, including any and all liabilities arising at any time under any Contract or Grant
                                            of Authority not included in the Assumed Contracts and Grants of Authority.

 

16.4
Procedure for Indemnification. The procedure for indemnification shall be as follows:

 

		(a)	Notice.
                                            The party claiming indemnification pursuant to this Agreement (the “Claimant”)
                                            shall promptly give notice to the party from whom indemnification is claimed (the “Indemnitor”)
                                            of any claim, whether solely between the parties or brought by a third party, specifying
                                            the factual basis for the claim, and the amount of the claim.

 

		(b)	Investigation.
                                            With respect to claims between the parties, following receipt of notice from the Claimant
                                            of a claim, the Indemnitor shall have thirty days to make any investigation of the claim
                                            that the Indemnitor deems necessary or desirable. For the purposes of this investigation,
                                            the Claimant agrees to make available to the Indemnitor and/or its authorized representatives
                                            the information relied upon by the Claimant to substantiate the claim. If the Claimant and
                                            the Indemnitor cannot agree as to the validity and amount of the claim within the 30-day
                                            period (or any mutually agreed upon extension thereof), the Claimant may seek appropriate
                                            legal remedy.

 

		(c)	Control.
                                            With respect to any claim by a third party as to which the Claimant is entitled to indemnification
                                            hereunder, the Indemnitor shall have the right at its own expense to participate in or assume
                                            control of the defense of the claim, and the Claimant shall cooperate fully with the Indemnitor,
                                            subject to reimbursement for actual out-of-pocket expenses incurred by the Claimant as the
                                            result of a request by the Indemnitor. If the Indemnitor elects to assume control of the
                                            defense of any third-party claim, the Claimant shall have the right to participate in the
                                            defense of the claim at its own expense. If the Indemnitor does not elect to assume control
                                            or otherwise participate in the defense of any third party claim, it shall be bound by the
                                            results obtained by the Claimant with respect to the claim.

 

    	29

    	 

    

 

SECTION
17. CERTAIN REMEDIES

 

17.1
Attorneys’ Fees. In the event of a default by Shareholder or Buyer which results in the filing of a lawsuit for damages,
specific performance, or other remedy, the prevailing party shall be entitled to reimbursement by the other party of reasonable legal
fees and expenses incurred.

 

SECTION
18. MISCELLANEOUS

 

18.1
Fees and Expenses. Shareholder shall pay any filing fees, transfer taxes, sales taxes, document stamps, or other charges
levied by any governmental entity on account of the transfer of the Shares from Shareholder to Buyer. Except as otherwise provided in
this Agreement, each party shall pay its own expenses incurred in connection with the authorization, preparation, execution, and performance
of this Agreement, including all fees and expenses of counsel, accountants, agents, and representatives.

 

18.2
Notices. All notices, demands, and requests required or permitted to be given under the provisions of this Agreement shall
be in writing and shall be deemed to have been duly delivered and received (a) on the date of personal delivery, or (b) on the earlier
of the date of receipt (as shown on the return receipt) or refusal of delivery if mailed by registered or certified mail, postage prepaid
and return receipt requested, or by email in each case addressed as follows:

 

If
to Shareholder:

 

Mr.
Jeremy Lyell

211
Shady Grove Road

Nashville,
Tennessee 37214

Email:
________________

  

If
to Company:

 

Mr.
Jeremy Lyell, President

Lyell
Environmental Services, Inc.

211
Shady Grove Road

Nashville,
Tennessee 37214

Email:
___________________

 

If
to Buyer:

 

Mr.
Lloyd Spencer

Deep
Green Waste & Recycling, Inc.

13110
NE 177th Place #293

Woodinville,
Washington 98072

Email:
Lloyd.spencer@deepgreenwaste.com

 

Or
to any other or additional persons and addresses as the parties may from time to time designate in a writing delivered in accordance
with this Section 13.2.

 

    	30

    	 

    

 

 

18.3
Benefit and Binding Effect. Neither party hereto may assign this Agreement without the prior written consent of the other
party hereto, except that, without the prior written consent of Shareholder, Buyer may assign its rights under this Agreement to any
entity controlling, controlled by or under common control with Buyer or any successor of Buyer by way of merger, acquisition, reorganization
or other similar corporate transaction, and, upon the assumption by such assignee of all liabilities and obligations of Buyer hereunder,
Buyer shall be released from all liabilities and obligations to Shareholder and the Company pursuant to this Agreement. This Agreement
shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns.

 

18.4
Further Assurances. The parties shall take any actions and execute any other documents that may be necessary or desirable
to the implementation and consummation of this Agreement, including, in the case of Shareholder, any additional bills of sale, deeds,
or other transfer documents that, in the reasonable opinion of Buyer, may be necessary to ensure, complete, and evidence the full and
effective transfer of the Shares to Buyer pursuant to this Agreement.

 

18.5
Governing Law. This Agreement shall be governed, construed, and enforced in accordance with the laws of the State of Washington
(without regard to the choice of law provisions thereof); and the parties consent to the jurisdiction of courts in the State of Washington
which shall be the venue for any and all actions or proceedings brought by a party hereto, arising out of or relating to this Agreement
or the Transaction Documents.

 

18.6
Headings. The headings herein are included for ease of reference only and shall not control or affect the meaning or construction
of the provisions of this Agreement.

 

    	31

    	 

    

 

18.7
Gender and Number. Words used herein regardless of the gender and number specifically used, shall be deemed and construed
to include any other gender, masculine, feminine, or neuter, and any other number, singular or plural, as the context requires.

 

18.8
Entire Agreement. This Agreement, all schedules and exhibits hereto, and all documents, certificates, and other documents
to be delivered by the parties pursuant hereto, collectively represent the entire understanding and agreement between Buyer and Shareholder
with respect to the subject matter hereof. This Agreement supersedes all prior negotiations between the parties and cannot be amended,
supplemented, or changed except by an agreement in writing that makes specific reference to this Agreement, and which is signed by the
party against which enforcement of any such amendment, supplement, or modification is sought.

 

18.9
Counterparts. This Agreement may be signed in counterparts with the same effect as if the signature on each counterpart
were upon the same instrument.

 

IN
WITNESS WHEREOF, this Agreement has been executed by Buyer, Shareholder, and the Company as of the date first written above.

 

	 	BUYER:
	 	 	 
	 	By:	 
	 	 	Lloyd
    Spencer, President
	 	 	 
	 	COMPANY:
	 	 	 
	 	By:	 
	 	 	Jeremy
    Lyell, President
	 	 	 
	 	 	SHAREHOLDER:
	 	 	 
	 	By:	 
	 	 	Jeremy
    Lyell

 

    	32

    	 

    

 

Schedules

 

	3.1.1	 	Share
    Certificate of Shareholder
	3.1.4	 	Notices
	3.5	 	Conflicts
	3.6	 	Consents
    and Approvals
	3.7	 	Financial
    Reports
	3.12	 	Contracts
	3.13	 	Claims
    and Legal Proceedings
	3.15	 	Intellectual
    Property
	3.16	 	Permits,
    Licenses, Accreditations, Certifications
	3.17	 	Related
    Party Transactions
	3.18	 	Articles,
    Bylaws, Minutes
	3.20
    	 	Insurance
    Policies
	3.21	 	Employees
    and Employee Plans
	3.26	 	Deposits
    and Prepayments
	5.9	 	Permitted
    Liabilities

 

Exhibits

Exhibit
A Escrow Agreement

 

    	33Exhibit
4.1

 

THE
REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT
EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR
HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER
THAN (I) THINKEQUITY, A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC., OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE
OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF THINKEQUITY, A DIVISION OF FORDHAM FINANCIAL MANAGEMENT, INC., OR OF ANY SUCH UNDERWRITER
OR SELECTED DEALER.

 

THIS
PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO FEBRUARY 9, 2022. VOID AFTER 5:00 P.M., EASTERN TIME, AUGUST 13, 2026.

 

WARRANT
TO PURCHASE COMMON STOCK

 

PETVIVO
HOLDINGS, INC.

 

	Warrant
    Shares:	Initial
    Exercise Date: February 9, 2022

 

THIS
WARRANT TO PURCHASE COMMON STOCK (the “Warrant”) certifies that, for value received, ________(the “Holder”)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
February 9, 2022 (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(f)(2)(G)(i), prior to at 5:00
p.m. (New York time) on the date that is five (5) years following the Effective Date (the “Termination Date”) but
not thereafter, to subscribe for and purchase from PetVivo Holdings, Inc., a Nevada corporation (the “Company”), up
to ____ shares of Common Stock, par value $0.001 per share, of the Company (the “Warrant Shares”), as subject to adjustment
hereunder. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section
2(b).

 

Section
1. Definitions. In addition to the terms defined elsewhere in this Agreement, the following terms have the meanings indicated
in this Section 1:

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Business
Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

 

“Commission”
means the United States Securities and Exchange Commission.

 

“Effective
Date” means the effective date of the registration statement on Form S-1 (File No. 333-249452), including any related prospectus
or prospectuses, for the registration of the Company’s common stock, par value $0.001 per share and the Warrant Shares under the
Securities Act, that the Company has filed with the Commission.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.

 

    	 

    	 

    

 

“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Trading
Day” means a day on which the New York Stock Exchange is open for trading.

 

“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).

 

“VWAP”
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of a share of Common Stock for such date (or the nearest preceding date) on the OTCQB or OTCQX as applicable, (c) if Common Stock
is not then listed or quoted for trading on the OTCQB or OTCQX and if prices for Common Stock are then reported in the “Pink Sheets”
published by OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most
recent bid price per share of Common Stock so reported, or (d) in all other cases, the fair market value of the Common Stock as determined
by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees and expenses of which
shall be paid by the Company.

 

Section
2. Exercise.

 

a)
Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on or after the Initial
Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of the Company as it may
designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly
executed facsimile copy (or e-mail attachment) of the Notice of Exercise Form annexed hereto. Within two (2) Trading Days following the
date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice
of Exercise by wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified
in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased
all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this
Warrant to the Company for cancellation within five (5) Trading Days of the date the final Notice of Exercise is delivered to the Company.
Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall
have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise Form within two (2) Business Days of receipt
of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions
of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof.

 

b)
Exercise Price. The exercise price per share of the Common Stock under this Warrant shall be $5.625, subject to adjustment hereunder
(the “Exercise Price”).

 

    	 

    	 

    

 

c)
Cashless Exercise. In lieu of exercising this Warrant by delivering the aggregate Exercise Price by wire transfer or cashier’s
check, at the election of the Holder this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless
exercise” in which the Holder shall be entitled to receive the number of Warrant Shares equal to the quotient obtained by dividing
[(A-B) (X)] by (A), where:

 

	 	(A)
    =	as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined
    in Rule 600(b)(64) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading
    Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular
    trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close
    of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
    Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
    pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;
	 	 	 
	 	(B)
    =	the
    Exercise Price of this Warrant, as adjusted hereunder; and
	 	 	 
	 	(X)
    =	the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.

 

If
Warrant Shares are issued in such a “cashless exercise,” the parties acknowledge and agree that in accordance with Section
3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised, and the
holding period of the Warrants being exercised may be tacked on to the holding period of the Warrant Shares. The Company agrees not to
take any position contrary to this Section 2(c).

 

Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).

 

d)
Mechanics of Exercise.

 

i.
Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
its transfer agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by Holder, or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 and, in either case, the Warrant Shares have been sold by the Holder prior to the Warrant Share Delivery Date (as
defined below), and otherwise by physical delivery of a certificate, registered in the Company’s share register in the name of
the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder in the Notice of Exercise by the date that is two (2) Trading Days after the delivery to the Company of the Notice
of Exercise (such date, the “Warrant Share Delivery Date”). If the Warrant Shares can be delivered via DWAC, the transfer
agent shall have received from the Company, at the expense of the Company, any legal opinions or other documentation required by it to
deliver such Warrant Shares without legend (subject to receipt by the Company of reasonable back up documentation from the Holder, including
with respect to affiliate status) and, if applicable and requested by the Company prior to the Warrant Share Delivery Date, the transfer
agent shall have received from the Holder a confirmation of sale of the Warrant Shares (provided the requirement of the Holder to provide
a confirmation as to the sale of Warrant Shares shall not be applicable to the issuance of unlegended Warrant Shares upon a cashless
exercise of this Warrant if the Warrant Shares are then eligible for resale pursuant to Rule 144(b)(1)). The Warrant Shares shall be
deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed to have become a holder
of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the Company of the Exercise
Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant to Section 2(d)(vi) prior
to the issuance of such shares, having been paid. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the second Trading Day following the Warrant Share Delivery Date, the Company shall pay to the Holder, in
cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the
Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading
Day after such liquidated damages begin to accrue) for each Trading Day after the second Trading Day following such Warrant Share Delivery
Date until such Warrant Shares are delivered or Holder rescinds such exercise.

 

    	 

    	 

    

 

ii.
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.

 

iii.
Rescission Rights. If the Company fails to cause its transfer agent to deliver to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise; provided, however,
that the Holder shall be required to return any Warrant Shares or Common Stock subject to any such rescinded exercise notice concurrently
with the return to Holder of the aggregate Exercise Price paid to the Company for such Warrant Shares and the restoration of Holder’s
right to acquire such Warrant Shares pursuant to this Warrant (including, issuance of a replacement warrant certificate evidencing such
restored right).

 

iv.
Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available to
the Holder, if the Company fails to cause its transfer agent to transmit to the Holder the Warrant Shares pursuant to an exercise on
or before the Warrant Share Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market
transaction or otherwise) or the Holder’s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction
of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy-In”),
then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder’s total purchase price (including
brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number
of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price
at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the
portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving
rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to
pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of
the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder’s right to
pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance
and/or injunctive relief with respect to the Company’s failure to timely deliver shares of Common Stock upon exercise of the Warrant
as required pursuant to the terms hereof.

 

    	 

    	 

    

 

v.
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.

 

vi.
Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all transfer agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.

 

vii.
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.

 

viii.
Signature. This Section 2 and the exercise form attached hereto set forth the totality of the procedures required of the Holder
in order to exercise this Purchase Warrant. Without limiting the preceding sentences, no ink-original exercise form shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any exercise form be required in order to exercise
this Purchase Warrant. No additional legal opinion, other information or instructions shall be required of the Holder to exercise this
Purchase Warrant. The Company shall honor exercises of this Purchase Warrant and shall deliver Shares underlying this Purchase Warrant
in accordance with the terms, conditions and time periods set forth herein.

 

    	 

    	 

    

 

e)
Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder’s Affiliates), would beneficially own in excess of the
Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially
owned by the Holder and its Affiliates shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon
(i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates and (ii)
exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation,
any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
owned by the Holder or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable shall be in
the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which
portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Company’s
transfer agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company
shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any
case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding shares
of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 9.99% of the number of shares of the
Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.
The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e),
provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of
this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st
day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner
otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be
defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary
or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder
of this Warrant.

 

Section
3. Certain Adjustments.

 

a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification. For the purposes of clarification, the Exercise Price
of this Warrant will not be adjusted in the event that the Company or any Subsidiary thereof, as applicable, sells or grants any option
to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale, grant or any option
to purchase or other disposition) any Common Stock or Common Stock Equivalents, at an effective price per share less than the Exercise
Price then in effect.

 

    	 

    	 

    

 

b)
[RESERVED]

 

c)
Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the
Holder’s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of
Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for
the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

d)
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend (other
than cash dividends) or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way
of return of capital or otherwise (including, without limitation, any distribution of shares or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,
however, to the extent that the Holder’s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the
time of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised this Warrant.

 

    	 

    	 

    

 

e)
Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock,
(iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization
of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for
other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding
shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated
or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each
a “Fundamental Transaction”), then, upon any subsequent exercise of this Warrant, the Holder shall have the right
to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number
of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional
consideration (the “Alternate Consideration”) receivable by holders of Common Stock as a result of such Fundamental
Transaction for each share of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without
regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price
among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.
If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then
the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such
Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor
(the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant in accordance
with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and
approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver
to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar
in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity
(or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard
to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the
exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant
to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise
price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction). Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for
(so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the “Company”
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.

 

f)
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

g)
Notice to Holder.

 

i.
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly mail to the Holder a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the
number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

    	 

    	 

    

 

ii.
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be mailed a notice to the Holder at its last address as it shall appear
upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified,
stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer
or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock
of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such
reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to provide such notice or any defect
therein shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice
provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company
shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled
to exercise this Warrant during the period commencing on the date of such notice to the effective date of the event triggering such notice
except as may otherwise be expressly set forth herein.

 

Section
4. Transfer of Warrant.

 

a)
Transferability. Pursuant to FINRA Rule 5110(g)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant
shall be sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call
transaction that would result in the effective economic disposition of the securities by any person for a period of 180 days immediately
following the date of effectiveness or commencement of sales of the offering pursuant to which this Warrant is being issued, except the
transfer of any security:

 

i.
by operation of law or by reason of reorganization of the Company;

 

ii.
to any FINRA member firm participating in the offering and the officers or partners thereof, if all securities so transferred remain
subject to the lock-up restriction in this Section 4(a) for the remainder of the time period;

 

iii.
if the aggregate amount of securities of the Company held by the Holder or related person do not exceed 1% of the securities being offered;

 

iv.
that is beneficially owned on a pro-rata basis by all equity owners of an investment fund, provided that no participating member manages
or otherwise directs investments by the fund, and participating members in the aggregate do not own more than 10% of the equity in the
fund; or

 

    	 

    	 

    

 

v.
the exercise or conversion of any security, if all securities received remain subject to the lock-up restriction in this Section 4(a)
for the remainder of the time period.

 

Subject
to the foregoing restriction, any applicable securities laws and the conditions set forth in Section 4(d), this Warrant and all rights
hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company assigning this Warrant
full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
having a new Warrant issued.

 

b)
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

c)
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
“Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.

 

d)
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.

 

Section
5. Registration Rights.

 

5.1
Demand Registration.

 

5.1.1
Grant of Right. The Company, upon written demand (a “Demand Notice”) of the Holder(s) of at least 51% of the Warrants
and/or the underlying Warrant Shares (“Majority Holders”), agrees to register, on one occasion, all or any portion of the
Warrant Shares underlying the Warrants (collectively, the “Registrable Securities”). On such occasion, the Company will file
a registration statement with the Commission covering the Registrable Securities within sixty (60) days after receipt of a Demand Notice
and use its commercially reasonable best efforts to have the registration statement declared effective promptly thereafter, subject to
compliance with review by the Commission; provided, however, that the Company shall not be required to comply with a Demand Notice if
the Company has filed a registration statement with respect to which the Holder is entitled to piggyback registration rights pursuant
to Section 5.2 hereof and either: (i) the Holder has elected to participate in the offering covered by such registration statement or
(ii) if such registration statement relates to an underwritten primary offering of securities of the Company, until the offering covered
by such registration statement has been withdrawn or until thirty (30) days after such offering is consummated. The demand for registration
may be made at any time beginning on the Initial Exercise Date and expiring on the fifth anniversary of the Effective Date. The Company
covenants and agrees to give written notice of its receipt of any Demand Notice by any Holder(s) to all other registered Holders of the
Warrants and/or the Registrable Securities within ten (10) days after the date of the receipt of any such Demand Notice.

 

    	 

    	 

    

 

5.1.2
Terms. The Company shall bear all fees and expenses attendant to the registration of the Registrable Securities pursuant to Section
5.1.1, but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to
represent them in connection with the sale of the Registrable Securities. The Company agrees to use its commercially reasonable best
efforts to cause the filing required herein to become effective promptly and to qualify or register the Registrable Securities in such
States as are reasonably requested by the Holder(s); provided, however, that in no event shall the Company be required to register the
Registrable Securities in a State in which such registration would cause: (i) the Company to be obligated to register or license to do
business in such State or submit to general service of process in such State, or (ii) the principal shareholders of the Company to be
obligated to escrow their shares of capital stock of the Company. The Company shall cause any registration statement filed pursuant to
the demand right granted under Section 5.1.1 to remain effective for a period of at least twelve (12) consecutive months after the date
that the Holders of the Registrable Securities covered by such registration statement are first given the opportunity to sell all of
such securities or until the shares can be sold under Rule 144. The Holders shall only use the prospectuses provided by the Company to
sell the Warrant Shares covered by such registration statement, and will immediately cease to use any prospectus furnished by the Company
if the Company advises the Holder that such prospectus may no longer be used due to a material misstatement or omission. Notwithstanding
the provisions of this Section 5.1.2, the Holder shall be entitled to a demand registration under this Section 5.1.2 on only one (1)
occasion and such demand registration right shall terminate on the fifth anniversary of the date of the Underwriting Agreement (as defined
below) in accordance with FINRA Rule 5110(f)(2)(G)(iv).

 

5.2
“Piggy-Back” Registration.

 

5.2.1
Grant of Right. In addition to the demand right of registration described in Section 5.1 hereof, the Holder shall have the right,
for a period of no more than two (2) years from the Initial Exercise Date in accordance with FINRA Rule 5110(f)(2)(G)(v), to include
the Registrable Securities as part of any other registration of securities filed by the Company (other than in connection with a transaction
contemplated by Rule 145(a) promulgated under the Securities Act or pursuant to Form S-8 or any equivalent form); provided, however,
that if, solely in connection with any primary underwritten public offering for the account of the Company, the managing underwriter(s)
thereof shall, in its reasonable discretion, impose a limitation on the number of Shares which may be included in the Registration Statement
because, in such underwriter(s)’ judgment, marketing or other factors dictate such limitation is necessary to facilitate public
distribution, then the Company shall be obligated to include in such Registration Statement only such limited portion of the Registrable
Securities with respect to which the Holder requested inclusion hereunder as the underwriter shall reasonably permit. Any exclusion of
Registrable Securities shall be made pro rata among the Holders seeking to include Registrable Securities in proportion to the number
of Registrable Securities sought to be included by such Holders; provided, however, that the Company shall not exclude any Registrable
Securities unless the Company has first excluded all outstanding securities, the holders of which are not entitled to inclusion of such
securities in such Registration Statement or are not entitled to pro rata inclusion with the Registrable Securities.

 

    	 

    	 

    

 

5.2.2
Terms. The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 5.2.1
hereof, but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders
to represent them in connection with the sale of the Registrable Securities. In the event of such a proposed registration, the Company
shall furnish the then Holders of outstanding Registrable Securities with not less than thirty (30) days written notice prior to the
proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration statement
filed by the Company during the two (2) year period following the Initial Exercise Date (unless all of the Registrable Securities have
been sold by the Holder.) The holders of the Registrable Securities shall exercise the “piggy-back” rights provided for herein
by giving written notice within ten (10) days of the receipt of the Company’s notice of its intention to file a registration statement.
Except as otherwise provided in this Warrant, there shall be no limit on the number of times the Holder may request registration under
this Section 5.2.2; provided, however, that such registration rights shall terminate on the second anniversary of the Initial Exercise
Date.

 

5.3
General Terms

 

5.3.1
Indemnification. The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration
statement hereunder and each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section
20 (a) of the Exchange Act against all loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and
other expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which any of them may become
subject under the Securities Act, the Exchange Act or otherwise, arising from such registration statement but only to the same extent
and with the same effect as the provisions pursuant to which the Company has agreed to indemnify the Underwriters contained in Section
5.1 of the Underwriting Agreement between ThinkEquity, a division of Fordham Financial Management, Inc., as representative of the Underwriters
and the Company, dated as of August 10, 2021 (the “Underwriting Agreement”). The Holder(s) of the Registrable Securities
to be sold pursuant to such registration statement, and their successors and assigns, shall severally, and not jointly, indemnify the
Company, against all loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses reasonably
incurred in investigating, preparing or defending against any claim whatsoever) to which they may become subject under the Securities
Act, the Exchange Act or otherwise, arising from information furnished by or on behalf of such Holders, or their successors or assigns,
in writing, for specific inclusion in such registration statement to the same extent and with the same effect as the provisions contained
in Section 5.2 of the Underwriting Agreement pursuant to which the Underwriters have agreed to indemnify the Company.

 

5.3.2
Exercise of Warrants. Nothing contained in this Warrant shall be construed as requiring the Holder(s) to exercise their Warrants
prior to or after the initial filing of any registration statement or the effectiveness thereof.

 

5.3.3
Documents Delivered to Holders. The Company shall furnish to each Holder participating in any of the foregoing offerings and to
each underwriter of any such offering, if any, a signed counterpart, addressed to such Holder or underwriter, of: (i) an opinion of counsel
to the Company, dated the effective date of such registration statement (and, if such registration includes an underwritten public offering,
an opinion dated the date of the closing under any underwriting agreement related thereto), and (ii) a “cold comfort” letter
dated the effective date of such registration statement (and, if such registration includes an underwritten public offering, a letter
dated the date of the closing under the underwriting agreement) signed by the independent registered public accounting firm which has
issued a report on the Company’s financial statements included in such registration statement, in each case covering substantially
the same matters with respect to such registration statement (and the prospectus included therein) and, in the case of such accountants’
letter, with respect to events subsequent to the date of such financial statements, as are customarily covered in opinions of issuer’s
counsel and in accountants’ letters delivered to underwriters in underwritten public offerings of securities. The Company shall
also deliver promptly to each Holder participating in the offering requesting the correspondence and memoranda described below and to
the managing underwriter, if any, copies of all correspondence between the Commission and the Company, its counsel or auditors and all
memoranda relating to discussions with the Commission or its staff with respect to the registration statement and permit each Holder
and underwriter to do such investigation, upon reasonable advance notice, with respect to information contained in or omitted from the
registration statement as it deems reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation
shall include access to books, records and properties and opportunities to discuss the business of the Company with its officers and
independent auditors, all to such reasonable extent and at such reasonable times as any such Holder shall reasonably request. If the
Company discloses any confidential and proprietary information to the Holder, the Holder agrees (i) to keep this information confidential,
(ii) not purchase or sell any securities of the Company based on this information and (iii) comply with all federal and state securities
laws and other applicable laws.

 

    	 

    	 

    

 

5.3.4
Underwriting Agreement. The Company shall enter into an underwriting agreement with the managing underwriter(s), if any, selected
by any Holders whose Registrable Securities are being registered pursuant to this Section 5, which managing underwriter shall be reasonably
satisfactory to the Company. Such agreement shall be reasonably satisfactory in form and substance to the Company, each Holder and such
managing underwriters, and shall contain such representations, warranties and covenants by the Company and such other terms as are customarily
contained in agreements of that type used by the managing underwriter. The Holders shall be parties to any underwriting agreement relating
to an underwritten sale of their Registrable Securities and may, at their option, require that any or all the representations, warranties
and covenants of the Company to or for the benefit of such underwriters shall also be made to and for the benefit of such Holders. Such
Holders shall not be required to make any representations or warranties to or agreements with the Company or the underwriters except
as they may relate to such Holders, their Warrant Shares and their intended methods of distribution.

 

5.3.5
Documents to be Delivered by Holder(s). Each of the Holder(s) participating in any of the foregoing offerings shall furnish to
the Company a completed and executed questionnaire provided by the Company requesting information customarily sought of selling security
holders.

 

Section
6. Miscellaneous.

 

a)
No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i).

 

b)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any certificate relating to the Warrant Shares, and
in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall
not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company
will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or
stock certificate.

 

c)
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.

 

d)
Authorized Shares.

 

The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).

 

    	 

    	 

    

 

Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.

 

Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.

 

e)
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Underwriting Agreement.

 

f)
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.

 

g)
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Underwriting Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

 

h)
Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Underwriting Agreement.

 

i)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.

 

j)
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k)
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.

 

l)
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.

 

m)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.

 

n)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.

 

********************

 

(Signature
Page Follows)

 

    	 

    	 

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.

 

	 	PETVIVO
    HOLDINGS, INC.
	 	 	 
	 	By:	 
	 	Name:	 John
    Lai
	 	Title:	 Chief
    Executive Officer and President 

 

    	 

    	 

    

 

NOTICE
OF EXERCISE

 

	 	TO:	PETVIVO
    HOLDINGS, INC.

	 	_______________________	 

 

(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2)
Payment shall take the form of (check applicable box):

 

[  ] in lawful money of the United States; or

 

[  ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).

 

(3)
Please register and issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

	 	 	 

 

The
Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:

 

	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

(4)
Accredited Investor. If the Warrant is being exercised via cash exercise, the undersigned is an “accredited investor”
as defined in Regulation D promulgated under the Securities Act of 1933, as amended

 

[SIGNATURE
OF HOLDER]

 

Name
of Investing Entity:____________________________________________________

 

Signature
of Authorized Signatory of Investing Entity: _____________________________

 

Name
of Authorized Signatory: _______________________________________________

 

Title
of Authorized Signatory: ________________________________________________

 

Date:
____________________________________________________________________

 

[Notice
of Exercise] 

    	 

    	 

    

 

ASSIGNMENT
FORM

 

(To
assign the foregoing warrant, execute

this
form and supply required information.

Do
not use this form to exercise the warrant.)

 

FOR
VALUE RECEIVED, [____] all of or [_______] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

_______________________________________________
whose address is

 

_______________________________________________________________.

 

_______________________________________________________________

 

	 	Dated:
    	 

 

	 	Holder’s
    Signature:	 	 
	 	 	 	 
	 	Holder’s
    Address:	 	 
	 	 	 	 
	 	 	 	 

 

NOTE:
The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement
or any change whatsoever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper
evidence of authority to assign the foregoing Warrant.

 

[Assignment
Form]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]